menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    European Patent Office declares CureVac mRNA patent valid

    REUTERS

    BioNTech Reports Q4, Full-Year 2024 Financials, Corporate Update

    GLOBENEWSWIRE

    Roche/BioNTech vaccine shows early promise in pancreatic cancer

    REUTERS

    FDA places BioNTech`s malaria vaccine study on clinical hold

    REUTERS

    BioNTech to Report Q4 and Full Year 2024 Financial Results

    GLOBENEWSWIRE

    I&I Startup Bambusa Nabs $90M for Bispecific Antibodies

    BIOSPACE

    BioNTech Completes Acquisition of Biotheus

    GLOBENEWSWIRE

    BioNTech Shares Pipeline Updates At J.P. Morgan Health Conference

    GLOBENEWSWIRE

    BioNTech settles with NIH, Penn over COVID vaccine royalties

    FIERCE PHARMA

    BioNTech posts overall survival data on would-be Keytruda killer

    FIERCE BIOTECH

    COVID Vaccines’ Genetic Mechanism Inadequately Tested, Reports

    GLOBENEWSWIRE

    BioNTech buys China`s Biotheus to support oncology strategy

    GLOBENEWSWIRE

    BioNTech`s COVID vaccine sales surpassed expectations in Q3

    FIERCE PHARMA

    BioNTech Reports Q3 2024 Results and Corporate Update

    GLOBENEWSWIRE

    BioNTech lowers full-year revenue outlook on COVID-19 seasonality

    REUTERS

    BioNTech to Host Innovation Series R&D Day on November 14, 2024

    GLOBENEWSWIRE

    BioNTech Reports Q3 2024 Results And Corporate Update On November 4

    GLOBENEWSWIRE

    FDA puts partial hold on BioNTech-OncoC4 phase 3 trial

    FIERCE BIOTECH

    Novavax Receives EU Authorization For Updated COVID Vaccine

    REUTERS

    Pfizer, BioNTech win bid to invalidate CureVac`s vaccine patents

    REUTERS

    BioNTech Highlights AI Capabilities and R&D at Inaugural AI Day

    PRESS RELEASE

    BioNTech Highlights AI Capabilities & R&D Use at Inaugural AI Day

    GLOBENEWSWIRE

    CHMP Backs Pfizer-BioNTech`s Omicron COVID-19 Vaccine

    GLOBENEWSWIRE

    BioNTech to Host AI Day on October 1, 2024

    GLOBENEWSWIRE

    BioNTech To Present Clinical Data Updates At ESMO Congress

    GLOBENEWSWIRE

    Tempus Announces Real World Data Collaboration with BioNTech

    BUSINESSWIRE

    Duality Plans Hong Kong IPO To Fund BioNTech-Partnered ADC Trials

    FIERCE BIOTECH

    Pfizer-BioNTech COVID-19 Vaccine Gets FDA Approval & Authorization

    BUSINESSWIRE

    US FDA approves updated COVID shots ahead of fall and winter

    REUTERS

    BioNTech says FDA lifts partial hold on its cancer drug trial

    REUTERS

    FDA allows BioNTech-MediLink ADC trial to resume with lower, safer doses

    FIERCE BIOTECH

    Pfizer, BioNTech’s Mixed Phase III Data Sets Back COVID-Flu Vaccine Candidate

    BIOSPACE

    Pfizer/BioNTech`s Combo Flu Shot Defeated By Influenza Strain B

    FIERCE BIOTECH

    Penn accuses BioNTech of skimping out on Comirnaty-related royalties in lawsuit

    FIERCE PHARMA

    BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update

    GLOBENEWSWIRE

    BioNTech ends work on Genmab-partnered bispecific antibody acasunlimab

    FIERCE BIOTECH

    BioNTech losses quadruple in Q2 amid shift to cancer drugs

    REUTERS

    Genmab Takes Full Control of Acasunlimab Development Program

    GLOBENEWSWIRE

    Moderna cuts 2024 sales forecast, sees low EU vaccine revenue into 2026

    REUTERS

    BioNTech Reports Positive Phase 2 Results For BNT111 In Melanoma

    GLOBENEWSWIRE

    BioNTech, Regeneron`s mRNA Cancer Candidate Wins In Phase 2 Trial

    FIERCE BIOTECH

    BioNTech signs 3D printing deal to develop oral RNA drugs

    ENDPTS

    BioNTech To Report Q2 2024 Results And Corporate Update August 5

    GLOBENEWSWIRE

    CureVac Updates On Patent Litigation Trial Dates Against Pfizer/BioNTech

    ACCESSWIRE

    Pfizer, BioNTech Get Positive CHMP Opinion for Omicron JN.1 COVID-19 Vaccine

    BUSINESSWIRE

    Pfizer and BioNTech Receive CHMP Opinion for Omicron JN.1 COVID-19 Vaccine

    GLOBENEWSWIRE

    BioNTech and DualityBio earn FDA Fast Track Designation for Prostate Cancer.

    GLOBENEWSWIRE

    FDA halts BioNTech ADC trial over `significant risk of illness`

    FIERCE PHARMA

    FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot

    REUTERS

    FDA recommends updated Covid-19 vaccines targeting JN.1

    PHARMACEUTICAL TECHNOLOGY

    BioNTech co-founder Özlem Türeci on ‘hip’ ADCs and the power of combo therapies

    ENDPTS

    BioNTech, CEPI Expand Partnership For Africa mRNA Vaccine Ecosystem

    GLOBENEWSWIRE

    BioNTech doubles down on ADC partner MediLink in new $1.8B biobucks pact

    ENDPTS

    Medigene`s BioNTech Research Deal Extended Beyond Initial Term

    GLOBENEWSWIRE

    BioNTech To Present Immunotherapy Updates At ASCO 2024

    GLOBENEWSWIRE

    Medigene & BioNTech Extend T Cell Receptor Immunotherapy Collaboration

    CONTRACT PHARMA

    Lyra to lay off 75% of its workers; Dupixent nears COPD decision

    ENDPTS

    Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe

    REUTERS

    BioNTech Shareholders Approve All 2024 AGM Agenda Items

    GLOBENEWSWIRE

    BioNTech looks to 2026 for commercial debut in oncology

    FIERCE PHARMA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.